Related Experiment Videos

Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade

J H Henriksen1, F Bendtsen, A L Gerbes

  • 1Department of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, Denmark.

Insights

In cirrhosis patients, higher sympathetic nervous activity correlated with lower central blood volume. Beta-blocker treatment did not significantly alter central blood volume but affected blood pressure and atrial pressure.

Area of Science:

  • Cardiovascular Physiology
  • Hepatology
  • Renal Physiology

Background:

  • Cirrhosis is associated with complex hemodynamic alterations and neurohormonal dysregulation.
  • Understanding the relationship between central blood volume and sympathetic nervous activity is crucial in managing cirrhotic patients.

Purpose of the Study:

  • To investigate the correlation between estimated central blood volume and sympathetic nervous activity in patients with cirrhosis.
  • To assess the impact of beta-adrenergic blockade on central blood volume and related hemodynamic parameters.

Main Methods:

  • Estimated central blood volume was calculated by multiplying cardiac output by mean transit time.
  • Sympathetic nervous activity was assessed using arterial and renal venous norepinephrine levels.
  • Hemodynamic parameters were measured before and after administration of oral propranolol.

Main Results:

  • Arterial and renal venous norepinephrine levels, indicators of sympathetic activity, were significantly higher in cirrhosis patients compared to controls.
  • A negative correlation was observed between sympathetic nervous activity and estimated central blood volume in patients with cirrhosis.
  • Beta-adrenergic blockade with propranolol did not significantly alter mean central blood volume, but decreased blood pressure and central blood volume in a subset of patients.

Conclusions:

  • Sympathetic nervous system overactivity in cirrhosis is associated with a reduced central blood volume.
  • Beta-blockade may influence central blood volume and arterial pressure, particularly in hemodynamically compromised cirrhotic patients.
  • Atrial natriuretic factor levels did not show a significant correlation with central blood volume in this patient cohort.

Related Concept Videos